La Jolla Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from La jolla pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In La Jolla Pharmaceutical Today - Breaking & Trending Today

La Jolla Pharmaceutical: Q1 Earnings Snapshot

WALTHAM, Mass. (AP) La Jolla Pharmaceutical Co. (LJPC) on Monday reported first-quarter. ....

United States , Jolla Pharmaceutical Co , Massachusetts Waltham , United States , North America , C Complete State National , Zacks Investment Research , La Jolla Pharmaceutical , 1 Earnings Snapshot , La Jolla Pharmaceutical Co , F Wire , Automated Insights ,

La Jolla Pharmaceutical (NASDAQ:LJPC) Now Covered by StockNews.com

StockNews.com began coverage on shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research downgraded La Jolla Pharmaceutical from a “buy” rating to a “hold” rating in a report on Wednesday, January […] ....

San Diego , United States , La Jolla , Marshall Wace , Zacks Investment Research , Jolla Pharmaceutical Co , Jolla Pharmaceutical Company Profile Get Rating , Get Rating , Jolla Pharmaceutical , Minvest Partners , Capital Management , Jolla Pharmaceutical Company Profile , La Jolla Pharmaceutical , Nasdaq Ljpc , Initiated Coverage , Stocknews Com ,

La Jolla Pharmaceutical (NASDAQ:LJPC) Stock Passes Above 50 Day Moving Average of $4.29

La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $4.29 and traded as high as $4.34. La Jolla Pharmaceutical shares last traded at $4.24, with a volume of 55,115 shares. Several analysts have issued reports on […] ....

San Diego , United States , La Jolla , Marshall Wace , Zacks Investment Research , Jolla Pharmaceutical Co , Jolla Pharmaceutical Company Profile , Get Rating , Jolla Pharmaceutical , Investment Research , Minvest Partners , Capital Management , La Jolla Pharmaceutical , Nasdaq Ljpc ,

La Jolla Pharmaceutical (NASDAQ:LJPC) Shares Purchased by Hollencrest Capital Management

Hollencrest Capital Management grew its stake in shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) by 94.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,355 shares of the biopharmaceutical company’s stock after acquiring an additional 40,000 […] ....

San Diego , United States , La Jolla , Davida Ramsay , Marshall Wace , Securities Exchange Commission , Zacks Investment Research , Jolla Pharmaceutical Co , Highvista Strategies , First Midwest Bank Trust Division , Connor Clark Lunn Investment Management Ltd , Hollencrest Capital Management , Get Rating , Capital Management , Lunn Investment Management , Vista Strategies , Midwest Bank Trust Division , Director David , Exchange Commission , Jolla Pharmaceutical , Visit Holdingschannel , La Jolla Pharmaceutical , Nasdaq Ljpc , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,